Elucid mHealth

About:

Elucid mHealth provide real-time remote monitoring tools for non-adherence and patient engagment within clinical trials.

Website: https://elucid-mhealth.com

Twitter/X: elucid_mhealth

Top Investors: Deepbridge Capital, Catapult Ventures, GM&C Life Sciences Fund

Description:

Elucid mHealth is a medication technology company creating adherence monitoring tools and virtual health platform aimed at improving clinical trial efficiencies. Elucid's novel product, Pill Connect, provides trial organizers with real-time adherence data and missed dose prevention, new dose data, protocol control, engagement measurements and automated dose reconciliation.

Total Funding Amount:

1.4M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Manchester, Manchester, United Kingdom

Founded Date:

2013-01-01

Contact Email:

info(AT)elucid-mhealth.com

Founders:

Farid Khan

Number of Employees:

1-10

Last Funding Date:

2017-09-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai